Plasmacytoid dendritic cells for treating cancer
AssigneePdc Line Pharma
InventorJoël PLUMAS
Life of this patent
Estimating the term…
Abstract
A method for treating and/or preventing cancer in a subject. The method includes administering to the subject a therapeutically effective amount of a population of plasmacytoid dendritic cells. The therapeutically effective amount of population of plasmacytoid dendritic cells is at least 5 million cells. The administration may be done 1 to 10 times daily.
Claims18
-17. (canceled)
A method for treating and/or preventing a cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a population of plasmacytoid dendritic cells (PDC), wherein said therapeutically effective amount is at least 5 million of cells.
Dependencies are inferred from the claim text.